European Journal of Immunology · 2007 · 29 citations · 54 references
Life SciencesImmunologyMolecular BiologyApoptosisAutoimmunityImmunoregulationB Cell ActivationB Cell BiologyB Cell DevelopmentCentral ToleranceHumoral ImmunityToll-like ReceptorsAutoreactive B Cell ActivationAutoreactive B Cell ResponsesB Cell Receptor EditingB-cell ToleranceCentral Tolerance MechanismsNegative SelectionPolyclonal B Cell ActivationToll-like Receptor-mediated B Cell Activation
Polyclonal activation of developing B cells is an injurious process, because most of these cells are nontolerant and express autoreactive receptors. CpG DNA is a polyclonal activator of mature B cells, but its effect on developing B cells is unclear. We tested whether developing, nontolerant B cells are responsive to mitogenic stimulation by CpG DNA and whether such a stimulus can interfere with the establishment of central tolerance. We found that developing B cells express Toll-like receptor 9 and undergo a polyclonal response to CpG DNA stimulation, as revealed by proliferation and differentiation to antibody-producing cells. In vitro and ex vivo experiments revealed that stimulation with CpG DNA protects immature B cells from negative selection imposed by apoptosis and receptor editing and results in the production of autoantibodies. Finally, we found that in vivo administration of CpG DNA activates immature B cells in the bone marrow and suppresses the expression of recombination-activating genes in a mouse model of central tolerance and receptor editing. These results suggest that mitogenic signals provided by CpG DNA stimulate nontolerant immature B cells in the bone marrow and have the potential to interfere with central tolerance.
54
A Toll-like receptor recognizes bacterial DNA
Hiroaki Hemmi, Osamu Takeuchi, Taro Kawai et al. · Nature · 2000 · 6.4K citations
Predominant Autoantibody Production by Early Human B Cell Precursors
Hedda Wardemann, Sergey Yurasov, Anne Schaefer et al. · Science · 2003 · 2.1K citations
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Osamu Adachi, Taro Kawai, Kiyoshi Takeda et al. · Immunity · 1998 · 2K citations · Full text